Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028052 · ClinicalTrials.gov registry record · NA
Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE)
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT02028052 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 37 participants.
The verdict
NCT02028052, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The objective of this study is comparing the attributable procedural time of Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) when sampling mediastinal and hilar lymph nodes with or without Rapid On-Site Evaluation (ROSE). The primary outcome will be the time elapsed from EBUS bronchoscope insertion to bronchoscope withdrawal. Secondary outcomes will include total number of sampled lymph nodes, average number of needle aspirations per lymph node sampled, overall diagnostic yield, and procedural time of the cytopathologist.
Interventions
- PROCEDURE ROSE
- DEVICE 22 gauge Vizishot needles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028052
The ClinicalTrials.gov registry entry for NCT02028052 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ROSE is the first listed.
NCT02028052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028052 about?
NCT02028052 is a clinical study titled "Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE)". The objective of this study is comparing the attributable procedural time of Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) when sampling mediastinal and hilar lymph nodes with or without Rapid On-Site Evaluation (ROSE). The primary outcome will be the time elapsed from EBUS...
What is the current status of trial NCT02028052?
This trial is currently terminated. It is a NA study. The enrollment target is 37 participants. The study started on 2012-04. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02028052?
The interventions under investigation include: ROSE (PROCEDURE), 22 gauge Vizishot needles (DEVICE).
Who is sponsoring clinical trial NCT02028052?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.